Share chart Odonate Therapeutics, Inc.
Extended chart
Simple chart
About Odonate Therapeutics, Inc.
Odonate Therapeutics, Inc., фармацевтическая компания, разрабатывает терапевтические средства для лечения рака. Он разрабатывает тесетаксел, перорально вводимый химиотерапевтический агент, который находится в стадии III клинического исследования для пациентов с метастатическим раком молочной железы. Компания была основана в 2013 году и базируется в Нью-Йорке, штат Нью-Йорк.IPO date | 2017-12-07 |
---|---|
ISIN | US6760791060 |
Industry | Pharmaceuticals |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Сайт | https://www.odonate.com |
Цена ао | 1.6 |
Change price per day: | 0% (1.29) |
---|---|
Change price per week: | -3.73% (1.34) |
Change price per month: | -0.7692% (1.3) |
Change price per 3 month: | -9.15% (1.42) |
Change price per half year: | -59.81% (3.21) |
Change price per year: | -93.27% (19.17) |
Change price per 3 year: | -92.25% (16.64) |
Change price per year to date: | -20.86% (1.63) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Kevin C. Tang | Chairman & CEO | 1 | 1967 (58 years) |
Mr. Michael S. Hearne | CFO & Principal Accounting Officer | 251.23k | 1963 (62 years) |
Mr. Ryan Cole | Sr. VP of Operations | N/A | |
Dr. Steven S. Pfeiffer Ph.D. | Sr. VP of Technical Operations | N/A | 1976 (49 years) |
Mr. Thomas Wei | Chief Scientific Officer | N/A | 1976 (49 years) |
Mr. Stewart M. Kroll | Chief Devel. Officer | N/A | 1959 (66 years) |
Ms. Tracey McKennon | Sr. VP of Quality Assurance | N/A | |
Ms. Jennifer Schroeder | Sr. VP of Program Management & Technology | N/A | |
Ms. Kim Ma | Sr. VP of Clinical Operations | N/A |
Address: United States, New York, NY , 3 East 28th Street - open in Google maps, open in Yandex maps
Website: https://www.odonate.com
Website: https://www.odonate.com